Provided by Tiger Trade Technology Pte. Ltd.

Biodesix, Inc.

29.45
-0.3800-1.27%
Volume:1K
Turnover:38.96K
Market Cap:310.73M
PE:-9.41
High:29.45
Open:29.45
Low:29.45
Close:29.83
52wk High:31.97
52wk Low:5.26
Shares:10.55M
Float Shares:4.98M
Volume Ratio:0.89
T/O Rate:0.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1298
EPS(LYR):-4.6702
ROE:-540.01%
ROA:-14.05%
PB:33.98
PE(LYR):-6.31

Loading ...

Biodesix Price Target Raised to $38.00/Share from $27.00 by HC Wainwright & Co.

Dow Jones
·
Sep 28

Biodesix, Inc. : H.c. Wainwright Raises Target Price to $38 from $27

THOMSON REUTERS
·
Sep 26

Biodesix Partners with Thermo Fisher on Tumor-Naïve MRD Blood Test Program

Reuters
·
Sep 24

Biodesix Advances Two Complementary Approaches to Molecular Residual Disease (Mrd) Monitoring

THOMSON REUTERS
·
Sep 24

Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings

GlobeNewswire
·
Sep 15

Biodesix Leadership to Present at Lake Street BIG10 Investor Conference

Reuters
·
Sep 03

Biodesix Earnings Call Highlights Rapid Growth Path

TIPRANKS
·
Aug 17

Veteran Insider Makes Bold New Bet on Biotech Player

TIPRANKS
·
Aug 14

Biodesix Insider Makes Bold New Move With Fresh Stock Purchase

TIPRANKS
·
Aug 13

Biodesix 10% Owner Jack W. Schuler Reports $669,537 Common Share Purchase

Reuters
·
Aug 13

Biodesix is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Aug 07

Biodesix price target raised to $27 from $26 at H.C. Wainwright

TIPRANKS
·
Aug 07

Analysts Conflicted on These Healthcare Names: Aurora Cannabis (ACB), Biodesix (BDSX) and Insulet (PODD)

TIPRANKS
·
Aug 06

Delcath Systems Q2 Revenue Rises, Beats Estimates

Reuters
·
Aug 06

Analysts Offer Insights on Healthcare Companies: Biodesix (BDSX), Pacific Biosciences (PACB) and Odyssey Therapeutics, Inc. (ODTX)

TIPRANKS
·
Aug 06

Biodesix Q2 2026 earnings: Diagnostic testing growth narrows losses

TradingKey
·
Aug 06

Biodesix Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Biodesix Q2 2026 Net Loss Narrows 37% to $7.3 Million; Revenue Climbs 34% to $26.9 Million

Reuters
·
Aug 06

Biodesix Q2 EPS $(0.71) Beats $(0.91) Estimate, Sales $26.861M Beat $26.026M Estimate

Benzinga Earnings
·
Aug 06

Biodesix Q2 Net Income USD -7.273 Million

Reuters
·
Aug 06